4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-071611
EVP, Research & CSO sold 1,375 shares at $39.95 ($54,931)
- EVP, Research & CSO acquired 1,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-28 | Exercise or conversion : show line 1 in the form | +1,375 | $1.53 | $2,104 | 109,075 | D |
| 2021-12-28 | Sale : show line 2 in the form | −1,375 | $39.95 | $54,931 | 107,700 | D |
| Open-market sales · 1,375 sh · avg $39.95 · $54,931 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-28 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −1,375 | 225,005 | D |
Loading xslF345X03/doc4.xml…